SUSAN THOMPSON: Open Payments
NPI 1992770853 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 14 payments from 7 companies in 2025. Trend: 2023 $1,783 · 2024 $1,804 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $176 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Axsome Therapeutics, Inc. | 1 | $37 |
| Alkermes, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: INVEGA SUSTENNA, REXULTI, CAPLYTA, Auvelity, LYBALVI, TRINTELLIX, COBENFY.
Industry payments across OK — which companies pay providers there.
